[ SBIR/STTR Rosters ]

The Oncology 2 – Translational Clinical Small Business Activities Special Emphasis Panels [OTC SBIR/STTR SEPs] review small business applications including Small Business Innovation Research [SBIR] and Small Business Technology Transfer [STTR] grant applications concerned with basic, preclinical, and clinical studies in the oncological sciences.

Cancer Diagnostics and Treatments SBIR/STTR SEP
[CDT ONC (12)]

This Special Emphasis Panel reviews grant applications related to diagnosis and treatment of cancer. This includes biomarkers as prognosticators of cancer, bioimmunotherapies of cancer, and novel approaches to treating cancer.

Specific areas covered by the CDT SBIR/STTR SEP include:

• Discovery and validation of biomarkers for cancer detection, diagnosis and prognosis
• Novel assays, instrumentation and analysis algorithm for cancer screening, and metastasis and survival prediction
• Basic, pre-clinical and clinical testing for tumor genetic and epigenetic variations
• Pre-clinical and clinical modeling of carcinogenesis, tumor development, metastasis, prevention and treatment
• Development and evaluation of cancer immunotherapeutic strategies in preclinical models, and translational studies leading to pilot and/or phase-1 clinical trials

Study section with most closely related areas of similar science listed in rank order are:

Genes, Genomes and Genetic SBIR/STTR SEP [GGG (10)] 
Bioengineering Sciences and Technology SBIR/STTR SEPs [BST SBIR/STTR SEPs] 
Immunology SBIR/STTR SEP [IMM-G] 
Digestive Sciences SBIR/STTR SEP [DIG (10)]  
Respiratory Sciences SBIR/STTR SEP [RES (10)]